A systematic review of cost-effectiveness analyses of biological DMARDs in rheumatoid arthritis

被引:0
|
作者
Richard, L. [1 ]
Brown, M. [2 ]
机构
[1] UCB Celltech, Slough, Berks, England
[2] UCB, Slough, Berks, England
关键词
D O I
10.1016/S1098-3015(10)64924-8
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A245 / A246
页数:2
相关论文
共 50 条
  • [41] AN UPDATED SYSTEMATIC REVIEW OF COST-EFFECTIVENESS ANALYSES OF DRUGS FOR OSTEOPOROSIS
    Li, N.
    Cornelissen, D.
    Silverman, S.
    Pinto, D.
    Si, L.
    Kremer, I.
    Bours, S.
    Boonen, A.
    Evers, S.
    van den Bergh, J.
    Reginster, J. -Y.
    Hiligsmann, M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S491 - S491
  • [42] A Systematic Review of Cost-Effectiveness Analyses for Hepatocellular Carcinoma Treatment
    Sydney C. Yuen
    Adaeze Q. Amaefule
    Hannah H. Kim
    Breanna-Verissa Owoo
    Emily F. Gorman
    T. Joseph Mattingly
    [J]. PharmacoEconomics - Open, 2022, 6 : 9 - 19
  • [43] Systematic Review of Cost-Effectiveness Analyses in US Spine Literature
    Chang, Diana
    Zygourakis, Corinna C.
    Wadhwa, Harsh
    Kahn, James
    [J]. NEUROSURGERY, 2020, 67 : 41 - 41
  • [44] Incorporating adherence in cost-effectiveness analyses of asthma: a systematic review
    Chongmelaxme, Bunchai
    Chaiyakunapruk, Nathorn
    Dilokthornsakul, Piyameth
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (06) : 554 - 566
  • [45] Cost-effectiveness analyses of osteoarthritis oral therapies: A systematic review
    Wielage R.C.
    Myers J.A.
    Klein R.W.
    Happich M.
    [J]. Applied Health Economics and Health Policy, 2013, 11 (6) : 593 - 618
  • [46] A systematic review of cost-effectiveness analyses of sequential treatment for osteoporosis
    Yu, Guangyi
    Tong, Suiju
    Liu, Jinyu
    Wan, Yuansheng
    Wan, Min
    Li, Sujuan
    You, Ruxu
    [J]. OSTEOPOROSIS INTERNATIONAL, 2023, 34 (04) : 641 - 658
  • [47] A Systematic Review of Cost-Effectiveness Analyses of Drugs for Postmenopausal Osteoporosis
    Hiligsmann, Mickael
    Evers, Silvia M.
    Ben Sedrine, Wafa
    Kanis, John A.
    Ramaekers, Bram
    Reginster, Jean-Yves
    Silverman, Stuart
    Wyers, Caroline E.
    Boonen, Annelies
    [J]. PHARMACOECONOMICS, 2015, 33 (03) : 205 - 224
  • [48] Cost-effectiveness of biological therapy compared with methotrexate in the treatment for rheumatoid arthritis in Colombia
    Carolina Valle-Mercado
    Maria-Fernanda Cubides
    Monica Parra-Torrado
    Diego Rosselli
    [J]. Rheumatology International, 2013, 33 : 2993 - 2997
  • [49] Cost-effectiveness of biological therapy compared with methotrexate in the treatment for rheumatoid arthritis in Colombia
    Valle-Mercado, Carolina
    Cubides, Maria-Fernanda
    Parra-Torrado, Monica
    Rosselli, Diego
    [J]. RHEUMATOLOGY INTERNATIONAL, 2013, 33 (12) : 2993 - 2997
  • [50] Cost-effectiveness of rituximab strategies in rheumatoid arthritis
    Seror, Raphaele
    Mariette, Xavier
    [J]. LANCET, 2017, 389 (10067): : 365 - 366